Development of binary classification models for assessment of drug-induced liver injury in humans using a large set of FDA-approved drugs

Ai, 2018, Predicting drug-induced liver injury using ensemble learning methods and molecular fingerprints, Toxicological Sciences, 165, 100, 10.1093/toxsci/kfy121 Assis, 2009, Human drug hepatotoxicity: A contemporary clinical perspective, Expert Opinion on Drug Metabolism & Toxicology, 5, 463, 10.1517/17425250902927386 Bajorath, 2014, Exploring activity cliffs from a chemoinformatics perspective, Molecular Informatics, 33, 438, 10.1002/minf.201400026 Béquignon, 2021, Computational approaches for drug-induced liver injury (DILI) prediction: State of the art and challenges, Systems Medicine Integrative, Qualitative and Computational Approaches, 2, 308 Berger, 2013 Berggren, 2012, Outlook for the next 5 years in drug innovation, Nature Reviews. Drug Discovery, 11, 435, 10.1038/nrd3744 Box, 2011 Chen, 2013, High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury, Hepatology, 58, 388, 10.1002/hep.26208 Cheng, 2003, In silico models for the prediction of dose-dependent human hepatotoxicity, Journal of Computer-Aided Molecular Design, 17, 811, 10.1023/B:JCAM.0000021834.50768.c6 Corsini, 2012, Current challenges and controversies in drug-induced liver injury, Drug Safety, 35, 1099, 10.1007/BF03261997 Davis, 1991, Handbook of genetic algorithms Dimova, 2016, Advances in activity cliff research, Molecular Informatics, 35, 181, 10.1002/minf.201600023 Egan, 2004, In silico prediction of drug safety: Despite progress there is abundant room for improvement, Drug Discovery Today, 1, 381, 10.1016/j.ddtec.2004.11.002 Greene, 2010, Developing structure-activity relationships for the prediction of hepatotoxicity, Chemical Research in Toxicology, 23, 1215, 10.1021/tx1000865 He, 2019, An in silico model for predicting drug-induced hepatotoxicity, International Journal of Molecular Sciences, 20, 1897, 10.3390/ijms20081897 Hewitt, 2013, Hepatotoxicity: A scheme for generating chemical categories for read-across, structural alerts and insights into mechanism(s) of action, Critical Reviews in Toxicology, 43, 537, 10.3109/10408444.2013.811215 Holt, 2010, Drug-induced liver injury, Annals of Internal Medicine, 137, 3 Hoofnagle, 2013, Livertox: A website on drug-induced liver injury, Hepatology, 57, 873, 10.1002/hep.26175 Kaplowitz, 2005, Idiosyncratic drug hepatotoxicity, Nature Reviews. Drug Discovery, 4, 489, 10.1038/nrd1750 Kola, 2004, Can the pharmaceutical industry reduce attrition rates?, Nature Reviews. Drug Discovery, 3, 711, 10.1038/nrd1470 Kullak-Ublick, 2017, Drug-induced liver injury: Recent advances in diagnosis and risk assessment, Gut, 66, 1154, 10.1136/gutjnl-2016-313369 Kuna, 2018, Models of drug induced liver injury (DILI) - current issues and future perspectives, Current Drug Metabolism, 19, 830, 10.2174/1389200219666180523095355 Liu, 2019, Three-level hepatotoxicity prediction system based on adverse hepatic effects, Molecular Pharmaceutics, 16, 393, 10.1021/acs.molpharmaceut.8b01048 Liu, 2015, Data-driven identification of structural alerts for mitigating the risk of drug-induced human liver injuries, The Journal of Information Literacy, 7, 4 OECD, 2014, Guidance document on the validation of (quantitative) structure-activity relationship [(Q)SAR] models, 1 Parasrampuria, 2018, Why drugs fail in late stages of development: Case study analyses from the last decade and recommendations, The AAPS Journal, 20, 46, 10.1208/s12248-018-0204-y Regev, 2014, Drug-induced liver injury and drug development: Industry perspective, Seminars in Liver Disease, 34, 227, 10.1055/s-0034-1375962 Rogers, 2005, Using extended connectivity fingerprints with Laplacian-modified Bayesian analysis in high-throughput screening follow-up, Journal of Biomolecular Screening, 10, 682, 10.1177/1087057105281365 Rogers, 2010, Extended-connectivity fingerprints, Journal of Chemical Information and Modeling, 50, 742, 10.1021/ci100050t Siramshetty, 2016, Withdrawn—A resource for withdrawn and discontinued drugs, Nucleic Acids Research, 44, 1080, 10.1093/nar/gkv1192 Strobl, 2009, An introduction to recursive partitioning: Rationale, application, and characteristics of classification and regression trees, bagging, and random forests, Psychological Methods, 14, 323, 10.1037/a0016973 Thakkar, 2020, Drug-induced liver injury severity and toxicity (DILIst): Binary classification of 1279 drugs by human hepatotoxicity, Drug Discovery Today, 225, 201, 10.1016/j.drudis.2019.09.022 van Tonder, 2013, Pre-clinical assessment of the potential intrinsic hepatotoxicity of candidate drugs Wang, 2019, In silico prediction of drug-induced liver injury based on ensemble classifier method, International Journal of Molecular Sciences, 20, 4106, 10.3390/ijms20174106 Watkins, 2005, Insight into hepatotoxicity: The troglitazone experience, Hepatology, 41, 229, 10.1002/hep.20598 Wu, 2019, In silico identification and mechanism exploration of hepatotoxic ingredients in traditional Chinese medicine, Frontiers in Pharmacology, 10, 1, 10.3389/fphar.2019.00458 Zhang, 2016, Predicting drug-induced liver injury in human with Naïve Bayes classifier approach, Journal of Computer-Aided Molecular Design, 30, 889, 10.1007/s10822-016-9972-6 Zhang, 2020, Development of novel in silico prediction model for drug-induced ototoxicity by using naïve Bayes classifier approach, Toxicology In Vitro, 65, 10.1016/j.tiv.2020.104812 Zhang, 2018, Development and evaluation of in silico prediction model for drug-induced respiratory toxicity by using naïve Bayes classifier method, Food and Chemical Toxicology, 121, 593, 10.1016/j.fct.2018.09.051 Zhang, 2020, Developing novel computational prediction models for assessing chemical induced neurotoxicity using naive Bayes classifier technique, Food and Chemical Toxicology, 143, 10.1016/j.fct.2020.111513